Quantcast

Latest Sunitinib Stories

2008-09-05 06:00:23

Cancer drug developer Antisoma has started a Phase II study of AS1411 in metastatic renal cell carcinoma. The single-arm trial will enroll around 30 patients intolerant to, or having relapsed after, previous treatments including a tyrosine kinase inhibitor (sunitinib or sorafenib). It will evaluate the safety and efficacy of AS1411 monotherapy given at 40 mg/kg/day for four days every 28 days for up to two cycles. Efficacy measures in the trial include response rate, time to progression...

2008-09-05 06:00:22

By LYNDSAY MOSS HEALTH CORRESPONDENT PATIENTS should be allowed to pay privately for cancer drugs and still keep their free NHS care in certain cases, the Scottish Government indicated yesterday. So-called co-payments - patients topping up their care with treatments not available on the NHS - have been banned by many Scottish health boards. But the government has now admitted current guidance on the controversial issue is not clear and has agreed to give new advice to the NHS. It...

2008-09-04 03:00:25

London, UK: 04 September 2008 - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announced that it has started a phase II study of AS1411 in metastatic renal cell carcinoma (kidney cancer). The single-arm trial will enrol around 30 patients intolerant to, or having relapsed after, previous treatments including a tyrosine kinase inhibitor (sunitinib or sorafenib). It will evaluate the safety and efficacy of AS1411 monotherapy given at 40 mg/kg/day for four days every 28 days...

2008-08-26 18:00:48

By Emma Brady Midlands cancer patients are being kept in the dark about new treatments that could extend their lives, it was claimed today. One in four myeloma specialists questioned in a survey admitted hiding facts about new treatments that may be tough to obtain on the NHS, citing the main reason was to avoid upsetting or confusing patients. The Myeloma UK poll comes less than three weeks after the National Institute for health and Clinical Excellence (Nice) issued draft guidance...

2008-08-25 09:00:26

Leading UK cancer experts have accused a health watchdog of forcing patients to remortgage their homes to afford treatments freely available in Europe. The group of 26 professors were "dismayed" at guidance issued by the National Institute for Health and Clinical Excellence (Nice) to deny patients four vital kidney cancer drugs on the NHS. They said the decision showed it was time for a "radical change" in how the NHS makes decisions on what treatments are available for cancer sufferers....

2008-08-25 09:00:26

By Nicola Fenwick CANCER experts have accused a health watchdog of forcing patients to remortgage their homes to pay for treatments freely available in Europe. The group of 26 professors are dismayed at guidance issued by the National Institute for Health and Clinical Excellence (Nice) that deny four kidney cancer drugs on the NHS. Earlier this month, Nice said the drugs + Sutent (sunitinib), Avastin (bevacizumab), Nexavar (sorafenib) and Torisel (temsirolimus) ? were not...

2008-08-20 09:00:22

The National Institute for Health and Clinical Excellence, UK has rejected four kidney cancer treatments for use on the National Health Service on grounds that the drugs are not cost effective, according to PharmaTimes. The draft guidance issued by the National Institute for Health and Clinical Excellence (NICE), contends that Roche's Avastin (bevacizumab), Bayer's Nexavar (sorafenib), Pfizer's Sutent (sunitinib) and Wyeth's Torisel (temsirolimus) are costly for the treatment of advanced or...

2008-08-18 09:01:01

By Gavin Engelbrecht THE Government?s drugs approval agency warned last night it might not be able to meet a pledge to speed up decision-making on new treatments. Campaigners and patients have criticised Nice ? the National Institute for Health and Clinical Excellence ? over the time it takes to approve lifegiving drugs. Health Secretary Alan Johnson has pledged to bring decision- making on new drugs down from an average length of two years to only three months. But Andrew Dillon, the...

2008-08-17 18:00:52

Regarding the drug Sutent which was refused to Mrs Hopkins who dedicated 42 years of her life to the health service, all I can ask is how can we afford to give benefits to some of these immigrants who have never put a single penny into our communities? It seems to me the less you work, the more help you seem to get. J GRIFFITHS Hanley (c) 2008 Sentinel, The (Stoke-on-Trent UK). Provided by ProQuest LLC. All rights Reserved.

2008-08-17 18:00:12

A Leading Welsh cancer specialist has condemned plans to prevent patients with advanced kidney cancer from getting specialised drug treatments. The National Institute for Health and Clinical Excellence (Nice) has issued draft guidance rejecting the use of Sutent, Avastin, Nexavar and Torisel on cost grounds, leaving only interferon available to clinicians. John Wagstaff, honorary consultant in medical oncology at the South Wales Cancer Institute in Swansea and director of the Wales Cancer...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related